483
Bayer AGBayer AG – FDA 483, Mar 22, 2019
Record Details
Bayer Pharma AG in Leverkusen, Germany, was inspected and cited for multiple deficiencies in its manufacturing and control processes. Observations included inadequate laboratory control mechanisms, improper storage of labeling materials, insufficient cleaning and maintenance procedures, and incomplete batch production records. The firm also failed to establish adequate control procedures for manufacturing processes and properly identify production areas and equipment.
View Company Profile
ID · 9e84a5c7-4f9e-40e6-8562-b1ae8d632e50
Other documents for Bayer AG
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.